Edgestream Partners’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7,117
| Closed | -$2.51M | – | 1088 |
|
|
2024
Q4 | $2.51M | Buy |
7,117
+2,696
| +61% | +$951K | 0.11% | 348 |
|
|
2024
Q3 | $1.58M | Buy |
+4,421
| New | +$1.58M | 0.07% | 467 |
|
|
2024
Q2 | – | Sell |
-2,558
| Closed | -$588K | – | 1049 |
|
|
2024
Q1 | $588K | Sell |
2,558
-2,614
| -51% | -$600K | 0.03% | 608 |
|
|
2023
Q4 | $1.14M | Sell |
5,172
-5,259
| -50% | -$1.16M | 0.08% | 404 |
|
|
2023
Q3 | $2.36M | Buy |
10,431
+6,370
| +157% | +$1.44M | 0.19% | 150 |
|
|
2023
Q2 | $896K | Buy |
+4,061
| New | +$896K | 0.08% | 380 |
|
|
2022
Q3 | – | Sell |
-3,820
| Closed | -$900K | – | 618 |
|
|
2022
Q2 | $900K | Buy |
+3,820
| New | +$900K | 0.07% | 341 |
|
|
2021
Q4 | – | Sell |
-4,790
| Closed | -$884K | – | 588 |
|
|
2021
Q3 | $884K | Sell |
4,790
-5,141
| -52% | -$949K | 0.05% | 332 |
|
|
2021
Q2 | $1.78M | Buy |
+9,931
| New | +$1.78M | 0.11% | 234 |
|